AquaBounty Technologies, Inc. (AQB)
1.11
+0.01
(+0.91%)
USD |
NASDAQ |
Oct 16, 16:00
1.09
-0.02
(-1.80%)
After-Hours: 20:00
AquaBounty Technologies Enterprise Value : 3.828M for Oct. 16, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 16, 2026 | 3.828M |
| October 15, 2026 | 3.776M |
| October 14, 2026 | 3.468M |
| October 13, 2026 | 3.442M |
| October 12, 2026 | 3.313M |
| October 09, 2026 | 3.519M |
| October 08, 2026 | 3.129M |
| October 07, 2026 | 2.868M |
| October 06, 2026 | 2.616M |
| October 05, 2026 | 2.676M |
| October 02, 2026 | 2.876M |
| October 01, 2026 | 2.799M |
| September 30, 2026 | 2.881M |
| September 29, 2026 | 2.991M |
| September 28, 2026 | 2.996M |
| September 25, 2026 | 3.004M |
| September 24, 2026 | 2.651M |
| September 23, 2026 | 3.468M |
| September 22, 2026 | 3.725M |
| September 21, 2026 | 3.828M |
| September 18, 2026 | 3.982M |
| September 17, 2026 | 3.931M |
| September 16, 2026 | 3.828M |
| September 15, 2026 | 3.776M |
| September 14, 2026 | 4.034M |
| Date | Value |
|---|---|
| September 11, 2026 | 4.394M |
| September 10, 2026 | 3.570M |
| September 09, 2026 | 3.570M |
| September 08, 2026 | 3.931M |
| September 04, 2026 | 4.034M |
| September 03, 2026 | 4.188M |
| September 02, 2026 | 4.188M |
| September 01, 2026 | 4.240M |
| August 31, 2026 | 4.677M |
| August 28, 2026 | 4.548M |
| August 27, 2026 | 4.857M |
| August 26, 2026 | 4.754M |
| August 25, 2026 | 4.960M |
| August 24, 2026 | 4.857M |
| August 21, 2026 | 4.857M |
| August 20, 2026 | 4.857M |
| August 19, 2026 | 4.960M |
| August 18, 2026 | 5.218M |
| August 17, 2026 | 5.320M |
| August 14, 2026 | 5.758M |
| August 13, 2026 | 5.835M |
| August 12, 2026 | 5.218M |
| August 11, 2026 | 5.784M |
| August 10, 2026 | 5.166M |
| August 07, 2026 | 4.137M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.409B |
| Agenus, Inc. | 522.06M |
| Alnylam Pharmaceuticals, Inc. | 30.68B |
| Amgen, Inc. | 277.12B |
| Anika Therapeutics, Inc. | 254.23M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.332M |
| Total Expenses (Quarterly) | 1.332M |
| EPS Diluted (Quarterly) | -0.3169 |
| Earnings Yield | -412.8% |
| Normalized Earnings Yield | -432.59 |